Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | HALO |
---|---|---|
09:32 ET | 13394 | 59.805 |
09:33 ET | 1600 | 59.77 |
09:35 ET | 2257 | 59.32 |
09:37 ET | 600 | 59.27 |
09:39 ET | 2595 | 59.72 |
09:42 ET | 500 | 59.54 |
09:44 ET | 1232 | 59.73 |
09:46 ET | 700 | 59.85 |
09:48 ET | 2551 | 59.97 |
09:50 ET | 2333 | 59.8 |
09:51 ET | 702 | 59.665 |
09:53 ET | 1114 | 59.69 |
09:55 ET | 565 | 59.6924 |
09:57 ET | 3008 | 59.76 |
10:00 ET | 100 | 59.81 |
10:02 ET | 3817 | 59.68 |
10:04 ET | 1034 | 59.655 |
10:06 ET | 4102 | 59.86 |
10:08 ET | 906 | 59.83 |
10:09 ET | 1962 | 59.89 |
10:11 ET | 500 | 59.99 |
10:13 ET | 9780 | 59.97 |
10:15 ET | 1019 | 60.04 |
10:18 ET | 1949 | 59.88 |
10:20 ET | 200 | 59.88 |
10:22 ET | 1116 | 59.825 |
10:24 ET | 800 | 59.85 |
10:26 ET | 200 | 59.835 |
10:27 ET | 360 | 59.81 |
10:29 ET | 4681 | 59.875 |
10:31 ET | 5606 | 60.05 |
10:33 ET | 4121 | 60.08 |
10:36 ET | 2218 | 60.28 |
10:38 ET | 5992 | 60.29 |
10:40 ET | 1726 | 60.265 |
10:42 ET | 2212 | 60.23 |
10:44 ET | 800 | 60.285 |
10:45 ET | 2081 | 60.23 |
10:47 ET | 1447 | 60.38 |
10:49 ET | 1337 | 60.27 |
10:51 ET | 449 | 60.33 |
10:54 ET | 900 | 60.35 |
10:56 ET | 929 | 60.37 |
10:58 ET | 803 | 60.36 |
11:00 ET | 1100 | 60.36 |
11:02 ET | 1218 | 60.26 |
11:03 ET | 1965 | 60.225 |
11:05 ET | 100 | 60.1931 |
11:07 ET | 435 | 60.24 |
11:09 ET | 700 | 60.2 |
11:12 ET | 232 | 60.217375 |
11:14 ET | 800 | 60.255 |
11:16 ET | 200 | 60.255 |
11:18 ET | 1700 | 60.27 |
11:20 ET | 400 | 60.295 |
11:21 ET | 949 | 60.3328 |
11:23 ET | 799 | 60.34 |
11:25 ET | 1500 | 60.36 |
11:27 ET | 1460 | 60.36 |
11:30 ET | 1100 | 60.395 |
11:32 ET | 1204 | 60.38 |
11:34 ET | 500 | 60.35 |
11:36 ET | 1315 | 60.45 |
11:38 ET | 1700 | 60.435 |
11:39 ET | 1126 | 60.555 |
11:41 ET | 4954 | 60.505 |
11:43 ET | 600 | 60.46 |
11:45 ET | 223 | 60.52 |
11:48 ET | 300 | 60.45 |
11:50 ET | 100 | 60.44 |
11:52 ET | 951 | 60.395 |
11:54 ET | 1410 | 60.385 |
11:56 ET | 941 | 60.38 |
11:57 ET | 500 | 60.335 |
11:59 ET | 1300 | 60.24 |
12:01 ET | 4863 | 60.285 |
12:03 ET | 1802 | 60.49 |
12:06 ET | 1265 | 60.52 |
12:08 ET | 400 | 60.53 |
12:10 ET | 100 | 60.525 |
12:12 ET | 809 | 60.59 |
12:14 ET | 870 | 60.52 |
12:15 ET | 100 | 60.515 |
12:17 ET | 600 | 60.6 |
12:19 ET | 516 | 60.64 |
12:21 ET | 3001 | 60.69 |
12:24 ET | 2825 | 60.775 |
12:26 ET | 2426 | 60.75 |
12:28 ET | 3513 | 60.94 |
12:30 ET | 1972 | 60.825 |
12:32 ET | 1130 | 60.83 |
12:33 ET | 535 | 60.79 |
12:35 ET | 631 | 60.86 |
12:37 ET | 3562 | 60.825 |
12:39 ET | 337 | 60.815 |
12:42 ET | 614 | 60.845 |
12:44 ET | 932 | 60.86 |
12:48 ET | 633 | 60.885 |
12:50 ET | 1401 | 60.85 |
12:51 ET | 525 | 60.835 |
12:53 ET | 500 | 60.84 |
12:55 ET | 308 | 60.835 |
12:57 ET | 700 | 60.81 |
01:00 ET | 700 | 60.78 |
01:02 ET | 715 | 60.82 |
01:04 ET | 1006 | 60.82 |
01:06 ET | 1000 | 60.82 |
01:08 ET | 600 | 60.82 |
01:09 ET | 500 | 60.835 |
01:11 ET | 975 | 60.815 |
01:13 ET | 1133 | 60.805 |
01:15 ET | 2007 | 60.825 |
01:18 ET | 5233 | 60.85 |
01:20 ET | 2276 | 60.81 |
01:22 ET | 1107 | 60.768 |
01:24 ET | 1100 | 60.72 |
01:26 ET | 300 | 60.685 |
01:27 ET | 1298 | 60.705 |
01:29 ET | 400 | 60.69 |
01:33 ET | 2550 | 60.78 |
01:36 ET | 2841 | 60.755 |
01:38 ET | 900 | 60.9 |
01:40 ET | 1309 | 60.85 |
01:42 ET | 895 | 60.8738 |
01:44 ET | 1207 | 60.86 |
01:45 ET | 3065 | 60.9559 |
01:47 ET | 1250 | 60.97 |
01:49 ET | 12343 | 61.015 |
01:51 ET | 300 | 61.005 |
01:54 ET | 700 | 60.98 |
01:56 ET | 1314 | 60.98 |
01:58 ET | 630 | 60.975 |
02:00 ET | 4385 | 60.83 |
02:02 ET | 1225 | 60.795 |
02:03 ET | 2185 | 60.775 |
02:05 ET | 1996 | 60.82 |
02:07 ET | 3894 | 60.925 |
02:09 ET | 4527 | 60.94 |
02:12 ET | 2163 | 61.03 |
02:14 ET | 920 | 60.965 |
02:16 ET | 500 | 60.88 |
02:18 ET | 1738 | 60.905 |
02:20 ET | 600 | 60.935 |
02:21 ET | 657 | 60.91 |
02:23 ET | 1235 | 60.895 |
02:25 ET | 2100 | 60.915 |
02:27 ET | 500 | 60.97 |
02:30 ET | 1561 | 60.955 |
02:32 ET | 6094 | 61.0599 |
02:34 ET | 300 | 61.075 |
02:36 ET | 1078 | 61.055 |
02:38 ET | 400 | 61.07 |
02:39 ET | 1102 | 61.065 |
02:41 ET | 600 | 61.055 |
02:43 ET | 1303 | 61.035 |
02:45 ET | 975 | 61.04 |
02:48 ET | 1568 | 61.09 |
02:50 ET | 1334 | 61.08 |
02:52 ET | 821 | 61.08 |
02:54 ET | 1427 | 61.005 |
02:56 ET | 1430 | 60.975 |
02:57 ET | 2481 | 61 |
02:59 ET | 3287 | 61.03 |
03:01 ET | 1771 | 61.03 |
03:03 ET | 1600 | 61.07 |
03:06 ET | 1970 | 61.12 |
03:08 ET | 950 | 61.15 |
03:10 ET | 1615 | 61.11 |
03:12 ET | 300 | 61.12 |
03:14 ET | 1300 | 61.015 |
03:15 ET | 2702 | 61.065 |
03:17 ET | 500 | 61.1 |
03:19 ET | 2084 | 61.1199 |
03:21 ET | 5806 | 61.155 |
03:24 ET | 1200 | 61.095 |
03:26 ET | 2000 | 61.05 |
03:28 ET | 3949 | 61 |
03:30 ET | 705 | 61.03 |
03:32 ET | 1736 | 61.04 |
03:33 ET | 1727 | 60.99 |
03:35 ET | 4624 | 60.97 |
03:37 ET | 3811 | 61.02 |
03:39 ET | 1513 | 61.06 |
03:42 ET | 6373 | 61 |
03:44 ET | 1991 | 61.05 |
03:46 ET | 8775 | 60.96 |
03:48 ET | 6102 | 60.97 |
03:50 ET | 500 | 60.99 |
03:51 ET | 11208 | 60.97 |
03:53 ET | 6026 | 61.03 |
03:55 ET | 12725 | 60.86 |
03:57 ET | 18876 | 60.92 |
04:00 ET | 327247 | 60.98 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Halozyme Therapeutics Inc | 7.8B | 20.2x | --- |
Supernus Pharmaceuticals Inc | 2.0B | 34.3x | -59.02% |
Phibro Animal Health Corp | 966.0M | 55.6x | -46.35% |
Eagle Pharmaceuticals Inc | 11.1M | 0.9x | -4.75% |
Elite Pharmaceuticals Inc | 544.6M | 26.6x | --- |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients. It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.8B |
---|---|
Revenue (TTM) | $947.4M |
Shares Outstanding | 127.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $3.02 |
Book Value | $0.66 |
P/E Ratio | 20.2x |
Price/Sales (TTM) | 8.2 |
Price/Cash Flow (TTM) | 16.4x |
Operating Margin | 50.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.